Trial intelligence / Profile preview

Tranexamic acid administration route in total knee arthroplasty

IRCT20190427043390N1Phase 2Completed

Sponsor
Iran University of Medical Sciences
Start
Sep 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, single-blind trial of tranexamic acid in primary osteoarthritis (OA) (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Mean amount of blood lost during and after surgery, Postoperative blood volume and 1 more. Started Sep 2016; status: completed.

02

Drugs

tranexamic acid
03

Conditions

primary osteoarthritis (OA)

Beyond the preview

Go deeper on IRCT20190427043390N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190427043390N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call